Conmed (CNMD) Operating Expenses (2010 - 2026)

Conmed (CNMD) has reported Operating Expenses for 17 consecutive years, with $161.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 7.25% year-over-year to $161.1 million; the trailing twelve-month figure through Jun 2026 stood at $655.0 million (up 14.69% YoY), and the FY2025 full-year result was $647.9 million, up 21.62% from the prior year.
• Operating Expenses rose to $161.1 million in Q2 2026 per CNMD's latest filing, from $158.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $181.7 million in Q4 2025 and bottomed at $113.3 million in Q3 2024.
• Historically, Operating Expenses has averaged $142.0 million across 5 years, with a median of $140.2 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses retreated 17.76% in 2024, then soared 36.15% in 2025.
• Over 5 years, Operating Expenses stood at $133.0 million in 2022, then slipped by 0.73% to $132.0 million in 2023, then increased by 10.5% to $145.8 million in 2024, then increased by 24.56% to $181.7 million in 2025, then slipped by 11.34% to $161.1 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $161.1 million, $158.0 million, and $181.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.